GRIECO, PAOLO
 Distribuzione geografica
Continente #
AS - Asia 7.539
EU - Europa 6.526
NA - Nord America 6.118
SA - Sud America 1.140
AF - Africa 186
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 11
Totale 21.531
Nazione #
US - Stati Uniti d'America 5.824
SG - Singapore 4.156
RU - Federazione Russa 3.112
CN - Cina 1.696
IT - Italia 1.098
BR - Brasile 943
HK - Hong Kong 711
VN - Vietnam 496
DE - Germania 412
FI - Finlandia 337
UA - Ucraina 315
IE - Irlanda 267
NL - Olanda 261
SE - Svezia 216
GB - Regno Unito 207
CA - Canada 176
FR - Francia 100
IN - India 95
AR - Argentina 80
MX - Messico 74
ZA - Sudafrica 57
BD - Bangladesh 54
CI - Costa d'Avorio 51
PL - Polonia 51
TR - Turchia 51
KR - Corea 47
ES - Italia 41
EC - Ecuador 34
JP - Giappone 34
ID - Indonesia 30
IQ - Iraq 28
BE - Belgio 24
IR - Iran 22
CO - Colombia 20
AT - Austria 19
PK - Pakistan 19
MA - Marocco 18
PY - Paraguay 18
SA - Arabia Saudita 14
LT - Lituania 13
BG - Bulgaria 12
CL - Cile 12
UY - Uruguay 12
VE - Venezuela 11
AE - Emirati Arabi Uniti 9
EU - Europa 9
IL - Israele 9
PE - Perù 9
UZ - Uzbekistan 9
CZ - Repubblica Ceca 8
HN - Honduras 8
DZ - Algeria 7
EG - Egitto 7
JM - Giamaica 7
KE - Kenya 7
NP - Nepal 7
TT - Trinidad e Tobago 7
AU - Australia 6
AZ - Azerbaigian 6
ET - Etiopia 5
GT - Guatemala 5
JO - Giordania 5
KZ - Kazakistan 5
MK - Macedonia 5
NZ - Nuova Zelanda 5
PA - Panama 5
AF - Afghanistan, Repubblica islamica di 4
BY - Bielorussia 4
LB - Libano 4
SN - Senegal 4
TN - Tunisia 4
BA - Bosnia-Erzegovina 3
BB - Barbados 3
CH - Svizzera 3
HU - Ungheria 3
KG - Kirghizistan 3
KH - Cambogia 3
PH - Filippine 3
PS - Palestinian Territory 3
TJ - Tagikistan 3
BH - Bahrain 2
BW - Botswana 2
BZ - Belize 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GA - Gabon 2
LY - Libia 2
MD - Moldavia 2
ML - Mali 2
MZ - Mozambico 2
OM - Oman 2
PT - Portogallo 2
RO - Romania 2
SV - El Salvador 2
TH - Thailandia 2
TZ - Tanzania 2
UG - Uganda 2
AD - Andorra 1
AL - Albania 1
AM - Armenia 1
Totale 21.502
Città #
Singapore 1.833
Moscow 750
Chandler 720
Hong Kong 707
Beijing 542
Ashburn 409
Naples 351
Santa Clara 326
Jacksonville 311
Hefei 295
Amsterdam 239
Princeton 218
Millbury 212
Los Angeles 192
Dallas 184
Boston 160
Ho Chi Minh City 160
Nanjing 159
Napoli 147
Buffalo 123
São Paulo 113
Munich 102
Wilmington 98
Ottawa 96
New York 93
The Dalles 89
Hanoi 86
Des Moines 77
Redondo Beach 76
Dong Ket 74
Woodbridge 69
Houston 65
Turku 55
Ann Arbor 51
Helsinki 49
Nanchang 47
Seattle 46
Warsaw 45
Seoul 44
Shenyang 40
Brooklyn 38
Frankfurt am Main 36
Mexico City 36
Norwalk 35
Rome 35
Chicago 33
Denver 32
Falkenstein 32
Rio de Janeiro 32
Stockholm 30
Hebei 29
Jiaxing 29
London 28
Montreal 28
Kronberg 27
Milan 27
Poplar 27
Changsha 26
Nuremberg 26
Dublin 25
Lawrence 25
Johannesburg 24
North Bergen 24
Tianjin 24
Boardman 23
Tokyo 23
Lappeenranta 22
Orem 22
Toronto 22
Atlanta 21
Chennai 20
Biên Hòa 19
Düsseldorf 19
Phoenix 19
Dearborn 18
Brasília 16
Columbus 16
Da Nang 16
Hangzhou 16
Belo Horizonte 15
Manchester 15
Charlotte 14
Falls Church 14
Brussels 13
Buenos Aires 13
Caserta 13
Haiphong 13
Porto Alegre 13
Ankara 12
Arce 12
San Francisco 12
Curitiba 11
Guayaquil 11
Hải Dương 11
Belfast 10
Guangzhou 10
Kunming 10
Ningbo 10
Pune 10
Querétaro 10
Totale 10.705
Nome #
" Molecular Modelingof the Urotensin-II receptor Complex" 212
Functional Selectivity Revealed by N-Methylation Scanning of Human Urotensin II and Related Peptides 200
Antimicrobial peptide Temporin-L complexed with anionic cyclodextrins results in a potent and safe agent against sessile bacteria 163
Screening Platform toward New Anti-HIV Aptamers Set on Molecular Docking and Fluorescence Quenching Techniques 160
Urokinase receptor derived peptides as potent inhibitors of the formyl peptide receptor type 1-triggered cell migration 156
Alanine scanning analysis and structure-function relationships of the frog-skin antimicrobial peptide temporin-1Ta 148
Microwave-Assisted Synthesis of 2-Methyl-1H-indole-3-carboxylate Derivatives via Pd-Catalyzed Heterocyclization 138
Unveiling the mechanism of action of acylated temporin L analogues against multidrug-resistant Candida albicans 138
Unraveling the active conformation of urotensin II 137
Urotensin II receptor on preoperative biopsy is associated with upstaging and upgrading in prostate cancer 136
An investigation into the origin of the biased agonism associated with the urotensin II receptor activation 133
Broad-Spectrum Antiviral Activity of the Amphibian Antimicrobial Peptide Temporin L and Its Analogs 129
"3D Structural analysis of Urotensin-II analogues in membrane mimetic environment" 129
Cyclization of the urokinase receptor-derived Ser-Arg-Ser-Arg-Tyr peptide generates a potent inhibitor of trans-endothelial migration of monocytes 129
Glycine-replaced derivatives of [Pro3,DLeu9]TL, a temporin L analogue: Evaluation of antimicrobial, cytotoxic and hemolytic activities 127
Discovery of New Potent Ligands at Human Urotensin-II Receptor 127
Synthesis and Pharmacological Evaluation of a Novel Peptide Based on Anemonia sulcata BDS-I Toxin as a New KV3.4 Inhibitor Exerting a Neuroprotective Effect Against Amyloid-β Peptide 123
The Outcomes of Decorated Prolines in the Discovery of Antimicrobial Peptides from Temporin-L 122
Novel Antimicrobial Peptide from Temporin L in The Treatment of Staphylococcus pseudintermedius and Malassezia pachydermatis in Polymicrobial Inter-Kingdom Infection 122
Antifungal and Antibiofilm Activity of Cyclic Temporin L Peptide Analogues against Albicans and Non-Albicans Candida Species 120
Urotensin II(4-11) Azasulfuryl Peptides: Synthesis and Biological Activity 120
Selective melanocortin MC4 receptor agonists reverse haemorrhagic shock and prevent multiple organ damage 119
Discovery of Novel Potent and Selective Agonists at the Melanocortin-3 Receptor 118
Synthesis, biological activity and conformational study of 1,4-benzoxazine dderivatives as potassium channel modulators. 117
Synthesis of novel lignan-like compounds and their antimicrobial activity 117
Unlocking the potential of protein-derived peptides to target G-quadruplex DNA: from recognition to anticancer activity 116
Structure-Activity Study of the Peptides P5U and Urantide by the Development of Analogues Containing Uncoded Amino Acids at Position9 116
Short PlGF-derived peptides bind VEGFR-1 and VEGFR-2 in vitro and on the surface of endothelial cells 116
The urokinase receptor-derived cyclic peptide [SRSRY] suppresses neovascularization and intravasation of osteosarcoma and chondrosarcoma cells 115
Synthesis and Binding Affinities for 5-HT1A, 5-HT2A and 5-HT2C receptors of a series of 1- and 2-(4-arylpiperazinylalkyl)-4-(benzoyl)-1,2,3-triazole derivatives. 113
Synthesis and in vitro activities of NK-1 antagonists derived from L-Triptophan. 113
Novel and Selective avb3 Receptor Peptide Antagonist: Design, Synthesis, and Biological Behavior 113
Improved synthesis on solid phase of dithiocarbamic cRGD-derivative and 99m Tc-radiolabelling 113
Phenol derived CVFM analogs inhibitors of ras farnesyl transferase possessing cellular in vitro activity. 112
Novel approach to the synthesis of diaza-bridged heterocycle derivative. 112
In vitro effects of protein fractions from Controne beans (Phaseolus vulgaris L. ecotype Controne) on intestinal permeability, ACE and α-amylase activities 112
Antimicrobial Activity of a Lipidated Temporin L Analogue against Carbapenemase-Producing Klebsiella pneumoniae Clinical Isolates 112
D-Amino Acids Containing Temporin L Analogues 111
Design, synthesis, and conformational analysis of Melanotropin analogues of MTII and SHU9119. 110
Novel α-MSH peptide analogues with broad spectrum antimicrobial activity. 109
Urotensin II receptor determines prognosis of bladder cancer regulating cell motility/invasion 109
Urotensin-II-Targeted Liposomes as a New Drug Delivery System towards Prostate and Colon Cancer Cells 109
A structure – activity relationship study on position –2 of the Gas C-terminal peptide able to inhibit Gs activation by A2A adenosine receptor. 108
Temporin L-derived peptide as a regulator of the acute inflammatory response in zymosan-induced peritonitis 108
The Anemonia sulcata Toxin BDS-I Protects Astrocytes Exposed to Aβ1–42 Oligomers by Restoring [Ca2+]i Transients and ER Ca2+ Signaling 108
Biophysical and biochemical characterization of a liposarcoma-derived recombinant MnSOD protein acting as an anticancer agent 107
Lead Optimization of P5U and Urantide: Discovery of Novel Potent Ligands at the Urotensin-II Receptor 107
Urantide Conformation and Interaction with the Urotensin-II Receptor 105
Synthesis and pharmacologi-cal activity of 2-(substituted)-3-{2-[(4-phenyl-4-cyano)piperidino]ethyl}-1,3-thiazolidin-4-ones. 104
Investigation on side-product formation during the synthesis of a lactoferrin-derived lactam-bridged cyclic peptide 104
Potential Functional Snacks: Date Fruit Bars Supplemented by Different Species of Lactobacillus spp 103
Ad-hoc modifications of cyclic mimetics of SOCS1 protein: Structural and functional insights 103
SAR study and conformational analysis of a series of novel peptide G protein-coupled receptor kinase 2 inhibitors 103
Chemical modifications in the seed region of miRNAs 221/222 increase the silencing performances in gastrointestinal stromal tumor cells 103
Breast tumor cell invasion and pro-invasive activity of cancer-associated fibroblasts co-targeted by novel urokinase-derived decapeptides 103
Synthetic Amphipathic β-Sheet Temporin-Derived Peptide with Dual Antibacterial and Anti-Inflammatory Activities 102
Synthesis of new pyrido[4,3-g and 3,4-g]quinoline-5,10-dione and dihydro thieno[[2,3-g and 3,2-g]quinoline-4,9-dione derivatives and perliminary evaluation of cytotoxic activity 102
Synthesis and antinociceptive Activity of Peptides Related to Interleukin-1b193-195 Lys-Pro-Thr. 102
The IkB Kinase Inhibitor, NEMO-binding Domain Peptide, inhibits rat balloon injury-induced neointimal formation. 101
Formulazione liquida micronizzabile per il trattamento terapeutico dell'acne e di altre patologie cutanee correlate 101
A new therapeutic approach to erectile dysfunction: Urotensin-II receptor high affinity agonist ligands 101
New insight into the binding mode of peptides at urotensin-II receptor by Trp-constrained analogues of P5U and urantide. 100
Design, synthesis and efficacy of novel G protein-coupled receptor kinase 2 inhibitors 100
NMR analysis of synthetic peptides agonist to PTPRJ, a receptor-type protein tyrosine phosphatase with tumor suppressor activity 100
NEW INSIGHT INTO THE BINDING MODE OF CYCLIC MELANOCORTIN LIGANDS AT THE MC4 RECEPTOR 100
Treatment with a Urokinase Receptor-derived Cyclized Peptide Improves Experimental Colitis by Preventing Monocyte Recruitment and Macrophage Polarization 100
Design, Synthesis, and Cytotoxic Evaluation of AcylDerivatives of 3-Aminonaphtho[2,3-b]thiophene-4,9-dione, a Quinone-Based System 99
Design, Synthesis, and Evaluation of Gluten Peptide Analogs as Selective 401 Inhibitors of Human TG2 99
Nanocarriers Conjugated with Cell Penetrating Peptides: New Trojan Horses by Modern Ulysses 99
Development of Macrocyclic Peptidomimetics Containing Constrained α,α-Dialkylated Amino Acids with Potent and Selective Activity at Human Melanocortin Receptors 99
Boosting Fmoc Solid-Phase Peptide Synthesis by Ultrasonication 99
Design and synthesis of the small libraries of peptidomimetics based on thiazolidine moiety 98
Urotensin II: A Novel Target in Human Corpus Cavernosum 98
Synthesis, Biological Activity and Conformational Study of 1,4-Benzoxazine Derivatives as Potassium Channel Modulators 98
null 98
Urotensin II receptor expression in patients with ulcerative colitis: a pilot study 98
Unveiling the interaction between DNA G-quadruplexes and RG-rich peptides 98
Urotensin-II Ligands: An Overview from Peptide to Nonpeptide Structures 97
Peptide functionalization of silicon for detection and classification of prostatic cells 97
Development of Cyclic Peptide Inhibitors of GRK2 96
Design, Synthesis, and Conformational Analysis of Melanotropin Analogues of MTII and SHU9119 96
HOST DEFENSE TEMPORIN 1 PEPTIDES AND THEIR POTENTIAL AS ANTIVIRAL AGENTS 96
Expanding Structure-Activity Relationships of Human Urotensin II Peptide Analogues: A Proposed Key Role of the N-Terminal Region for Novel Urotensin II Receptor Modulators 95
Characterization of KRAS Mutational Regression in Oligometastatic Patients 95
Cross-talk between fmlp and αvβ5 receptors triggered by urokinase receptor-derived SRSRY peptide 95
Synthesis and Pharmacological Evaluation of Analogs of Indole-Based Cannabimimetic Agents. 95
Design and Synthesis of Spirotryprostatin-inspired Diketopiperazine Systemsfrom Prolyl Spirooxoindolethiazolidine Derivatives 95
Synthesis of novel indol-based ring systems by acid-catalyzed condensation from -amino aldehydes and L-Trp-OMe 94
Development of a liposome-based formulation for vitamin K1 nebulization on the skin 94
Activation of Melanocortin Receptors MC1 and MC5 Attenuates Retinal Damage in Experimental Diabetic Retinopathy 94
Discovery of a new class of triazole based inhibitors of acetyl transferase KAT2A 93
A novel route to synthesize Freidinger lactams by microwave irradiation 93
A novel quinone–based derivative (DTNQ-Pro) induces apoptotic death via modulation/reduction of hsp expression in a human colon adenocarcinoma cell line 93
Structure-Activity Relationship, Conformational and Biological Studies of Temporin L Analogues 93
Rationally designed α-conotoxin analogues maintained analgesia activity and weakened side effects 93
“Matters Arising” on a Recent Biologic (Ab-IPL-IL-17™) for IL-17-Mediated Diseases 92
Binding site of loperamide: automated docking of loperamide in human mi - and delta -opioid receptors. 92
Identification of the Spiro(oxindole-3,3’-thiazolidine)-Based Derivatives as Potential p53 Activity Modulators 92
Synthesis and pharmacological evaluation of some 4-oxo-quinoline-2-carboxylic acid derivatives as anti-inflammatory and analgesic agents 92
DESIGN AND SYNTHESIS OF N-METHYL DERIVATIVES OF UROTENSIN-II 92
Totale 11.073
Categoria #
all - tutte 74.007
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.007


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021563 0 0 0 0 0 144 64 24 97 40 102 92
2021/20221.265 32 4 11 16 18 50 16 56 269 92 170 531
2022/20231.775 271 126 55 162 201 193 18 153 266 222 82 26
2023/20241.229 57 182 210 53 82 88 39 139 17 28 235 99
2024/20257.214 380 451 60 113 106 372 691 453 734 797 2.443 614
2025/20267.543 1.497 921 1.452 1.244 2.159 270 0 0 0 0 0 0
Totale 21.954